NCT06753734

Brief Summary

This study aim to develope novel breath markers of gestational diabetes through a prospective high-risk population cohort study and achieve early prediction of gestational diabetes based on an interpretable machine learning model.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
19mo left

Started Dec 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress47%
Dec 2024Dec 2027

First Submitted

Initial submission to the registry

December 23, 2024

Completed
2 days until next milestone

Study Start

First participant enrolled

December 25, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 31, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
1.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Expected
Last Updated

May 31, 2025

Status Verified

December 1, 2024

Enrollment Period

1.2 years

First QC Date

December 23, 2024

Last Update Submit

May 27, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of gestational diabetes mellitus

    24-28 weeks gestation

Study Arms (2)

Gestational Diabetes Group

control group

Eligibility Criteria

Age18 Years - 55 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

The population in this study include pregnant women aged 18-55 years and at 11-14 weeks gestation with at least one risk factor for GDM

You may not qualify if:

  • Diabetes mellitus or abnormal glucose metabolism before pregnancy
  • Hyperemesis gravidarum (urine ketone positive))
  • Thyroid dysfunction
  • Asthmatic patients
  • Hypertensive diseases that are difficult to control
  • Severe hepatic and renal insufficiency or severe electrolyte disturbance
  • Malignant tumor
  • Acute inflammation
  • lung disease
  • Patients with gastritis, duodenum and other digestive system diseases
  • Those with upper respiratory or oral problems who cannot cooperate with expiratory collection
  • smoker

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tianjin Central Hospital of Gynecology Obstetrics

Tianjin, China

Location

MeSH Terms

Conditions

Diabetes, Gestational

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 23, 2024

First Posted

December 31, 2024

Study Start

December 25, 2024

Primary Completion

March 1, 2026

Study Completion (Estimated)

December 1, 2027

Last Updated

May 31, 2025

Record last verified: 2024-12

Locations